|
Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies |
Xie L, Wei W, Pan C, Baser O |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Xie L, Wei W, Pan C, Baser O. Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies. Journal of Medical Economics 2013; 16(9): 1137-1145 Indexing Status Subject indexing assigned by NLM MeSH Adult; Aged; Blood Glucose /analysis; Cost Savings; Cost-Benefit Analysis; Databases, Factual; Diabetes Mellitus, Type 2 /diagnosis /drug therapy /economics; Disposable Equipment /economics; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Costs; Female; Humans; Hypoglycemia /economics /epidemiology /prevention & Hypoglycemic Agents /administration & Incidence; Injections, Subcutaneous; Insulin Glargine; Insulin, Long-Acting /administration & Logistic Models; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Retrospective Studies; Severity of Illness Index; Syringes /economics /statistics & control; dosage /economics; dosage /economics; numerical data AccessionNumber 22013041646 Date bibliographic record published 30/04/2014 |
|
|
|